[HTML][HTML] Thyroid cancers: from surgery to current and future systemic therapies through their molecular identities

L Lorusso, V Cappagli, L Valerio, C Giani… - International Journal of …, 2021 - mdpi.com
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …

[PDF][PDF] Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

L Lorusso, V Cappagli, L Valerio, C Giani… - Int. J. Mol …, 2021 - pdfs.semanticscholar.org
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

L Lorusso, V Cappagli, L Valerio… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …

Thyroid cancers: From surgery to current and future systemic therapies through their molecular identities

L Lorusso, V Cappagli, L Valerio, C Giani… - INTERNATIONAL …, 2021 - arpi.unipi.it
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …

[HTML][HTML] Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

L Lorusso, V Cappagli, L Valerio, C Giani… - … Journal of Molecular …, 2021 - ncbi.nlm.nih.gov
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities.

L Lorusso, V Cappagli, L Valerio, C Giani… - … Journal of Molecular …, 2021 - europepmc.org
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …

[PDF][PDF] Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

L Lorusso, V Cappagli, L Valerio, C Giani, D Viola… - Int. J. Mol. Sci, 2021 - academia.edu
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

L Lorusso, V Cappagli, L Valerio, C Giani, D Viola… - 2021 - agris.fao.org
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …

[PDF][PDF] Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

L Lorusso, V Cappagli, L Valerio, C Giani, D Viola… - Int. J. Mol. Sci, 2021 - arpi.unipi.it
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities.

L Lorusso, V Cappagli, L Valerio, C Giani… - … Journal of Molecular …, 2021 - europepmc.org
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …